ZBP1 and cancer: The small-molecule curaxin CBL0137 was found to reverse immune checkpoint blockade unresponsiveness in mouse models of melanoma, induce ZBP1-dependent necropsy in cancer-associated fibroblasts, and potently activate ZBP1 by triggering Z-DNA formation [166].